Ibrutinib intermediate
Ibrutinib intermediate is a small molecule drug that binds permanently to a protein, Bruton’s tyrosine kinase, that is important in B cells. It is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström’s macroglobulinemia
2380-63-4:
Specifications:
| Intermediate | CAS No’s | API/End Use | Status | Purity |
| 4-Aminopyrazolo[3,4-d]pyrimidine | 2380-63-4 | Ibrutinib | Commercial | NLT 99% |